Tirzepatide 10mg
As low as A$176.00/unit
Research Use Only: This product is sold for laboratory and in-vitro research purposes. Not for human consumption or therapeutic use.
Product Details
Health Benefits of Tirzepatide 10mg
Dual GLP-1/GIP Receptor Agonist
Tirzepatide is a first-in-class dual incretin agonist that activates both GLP-1 and GIP receptors. This dual mechanism of action provides superior glycaemic control and weight management compared to single-target GLP-1 agonists in clinical research.
Clinically Proven Weight Management
The SURMOUNT clinical trial programme demonstrated up to 22.5% body weight reduction over 72 weeks — significantly exceeding results from GLP-1-only agonists. These results represent a major advancement in metabolic peptide research.
Superior Glycaemic Control
The SURPASS clinical trials showed tirzepatide achieved HbA1c reductions of up to 2.58%, with 97% of participants reaching HbA1c <7%. It outperformed semaglutide head-to-head in the SURPASS-2 trial for both glycaemic control and weight loss.
Cardiovascular Risk Reduction
Research demonstrates tirzepatide improves multiple cardiovascular risk factors including blood pressure, triglycerides, LDL cholesterol, and inflammatory markers. The SELECT-2 trial is investigating cardiovascular outcomes directly.
Insulin Sensitivity Improvement
Studies show tirzepatide significantly improves insulin sensitivity — a key factor in type 2 diabetes and metabolic syndrome. The GIP receptor activation contributes to enhanced beta-cell function and glucose-dependent insulin secretion.
Appetite Regulation Research
Tirzepatide's dual incretin action provides robust appetite suppression through both central (hypothalamic) and peripheral (gut hormone) pathways, making it a key compound in satiety and feeding behaviour research.
Note: The health benefits listed above are based on published scientific research and clinical studies. Individual results may vary. This product is sold for research purposes only — not for human consumption. Always consult published literature for detailed study methodologies and findings.
Frequently Asked Questions — Tirzepatide 10mg
What is Tirzepatide?
Tirzepatide is a synthetic dual-acting peptide that simultaneously activates GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. Originally developed by Eli Lilly, it is FDA-approved as Mounjaro (for diabetes) and Zepbound (for weight management). It represents a major advancement in incretin-based peptide research.
How does Tirzepatide compare to Semaglutide?
Both are incretin-based peptides, but tirzepatide activates two receptors (GLP-1 + GIP) while semaglutide targets only GLP-1. Head-to-head trials (SURPASS-2) showed tirzepatide achieved greater HbA1c reduction and more weight loss than semaglutide. The dual mechanism provides synergistic metabolic benefits.
What is GIP and why does it matter?
GIP (glucose-dependent insulinotropic polypeptide) is a naturally occurring incretin hormone released from the gut after eating. It enhances insulin secretion, improves beta-cell function, and influences fat metabolism. Adding GIP receptor activation to GLP-1 agonism creates complementary metabolic effects not achievable with GLP-1 alone.
Can I buy Tirzepatide in Australia?
Yes — OzTideLab ships Tirzepatide 10mg across Australia via Australia Post. Free standard shipping on orders over A$199. HPLC-verified ≥98% purity, discreet packaging, and PayID/Osko payment accepted.
Research Applications
This peptide is supplied for in-vitro laboratory research only. Common research applications include receptor binding assays, cell culture studies, structure-activity relationship analysis, and bioassay development. Researchers should consult relevant literature for specific experimental protocols.
Storage & Handling
- • Store lyophilised powder at -20°C for long-term stability
- • Short-term storage: 2-8°C (refrigerated)
- • Protect from light, moisture, and repeated freeze-thaw cycles
- • Once reconstituted, use within the recommended timeframe
Purity & HPLC Analysis
Every batch is independently verified via High-Performance Liquid Chromatography (HPLC) to confirm ≥98% purity. Mass spectrometry (MS) is used for molecular identity confirmation. Certificates of Analysis (CoA) are available on request — email support@oztidelab.com with your order number.
Reconstitution Guidelines
- • Use bacteriostatic water or sterile water for reconstitution
- • Add solvent slowly along the vial wall — do not shake
- • Gently swirl until fully dissolved (clear solution)
- • Store reconstituted solution at 2-8°C and use within 28 days
- • Use sterile technique throughout to prevent contamination
HPLC Verified
≥98% purity certified
Australian Owned
Local team, local support
Discreet Shipping
Plain packaging AU-wide
Research Grade
Lab-quality peptides
